Biocon Limited 
Dealstreet

SAM, Khaitan, CAM act on Biocon Limited acquiring $1.2 billion stake in Biocon Biologics

Biocon Limited is acquiring the stake in Biocon Biologics through share swap arrangements with Viatris, Serum Institute Lifesciences, Tata Capital Growth Fund II and True North.

Bar & Bench

Biocon Limited has made acquisition of minority shareholdings in Biocon Biologics Limited from Viatris Inc, Serum Institute Lifesciences, Tata Capital Growth Fund II and True North, for ~$1.2 billion

Shardul Amarchand Mangaldas & Co advised Biocon Limited and its subsidiary Biocon Biologics on this transaction.

The Transaction Team was led by Raghubir Menon (Partner, Regional Practice Head – Mumbai, M&A and Private Equity, General Corporate) and Natashaa Shroff (Partner), along with Tarumoy Chaudhuri (Partner), Rounak Agarwal (Principal Associate) Kriti Saraswat, (Senior Associate), Associates Sohini Banerjee, Mihira Jaggi, and Anushya Ramakrishna. 

The Competition Team was led by Shweta Shroff Chopra (Partner) and Supritha Prodaturi (Partner), with support from Parinita Kare (Senior Associate), Associates Vasudha Verma, Saii S., and Janhavi Jyoti S..

The Capital Markets Team included Prashant Gupta (Partner – National Practice Head – Capital Markets), Ruth Chenchiah (Partner) and Debolina Mitra (Senior Associate).

The Banking & Finance Team comprised Shubhangi Garg (Partner) and Ansh Jain (Associate).

The Securities Team included Yogesh Chande (Partner) and Anushri Mandal (Associate).

Raghubir Menon, Natashaa Shroff

Khaitan & Co advised Viatris Inc on this transaction.

The core transaction team consisted of Rabindra Jhunjhunwala (Partner), Abhishek Dadoo (Partner), Aman Anand (Principal Associate), Gaurang Mansinghka (Senior Associate) and Nitya Saxena (Associate) with assistance from the following:

Banking aspects: Rajeev Vidhani (Partner) and Krishnendu Sen (Counsel);

Anti-trust aspects: Anisha Chand (Partner) and Yatharth Vardhan Singh (Senior Associate);

Taxation aspects: Ritu Shaktawat (Partner) and Husain Bohra (Senior Associate);

Capital markets aspects: Aditya Cheriyan (Partner) and Chirayu Chandani (Partner).

Rabindra Jhunjhunwala, Abhishek Dadoo

Cyril Amarchand Mangaldas advised Serum Institute on this transaction.

The transaction team was led by Anchal Dhir (Partner), with assistance from Varun Kannan (Senior Associate), Mahin Rai (Senior Associate) and Animesh Pandey (Associate). 

Avaantika Kakkar (Partner, Head - Competition) advised on competition law aspects of the transaction. 

Anchal Dhir

If you would like your Deals, Columns, Press Releases to be published on Bar & Bench, please fill in the form available here.

Bengaluru court awards ₹3.78 crore to whistleblower terminated by Willis Towers Watson

Pre-2019 consumer claims above ₹50 Lakh maintainable before State Commission: J&K High Court

Kerala High Court changes its internship policy; only those in final 2 years of LL.B allowed

Legal Notes by Arvind Datar: Tea with 103-year-old Taraporevala

ICC India Arbitration Conference 2026 to be held in Mumbai on October 31

SCROLL FOR NEXT